Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 39 references
Medicine
TL;DR
MMP2-high fibroblast states are identified as an important stromal feature of GC and FBXW7-associated regulation of intracellular MMP2 stability as a potential therapeutic vulnerability is revealed.
Abstract
Background Gastric cancer (GC) remains a major cause of cancer-related mortality, highlighting the need to clarify the stromal and post-translational mechanisms underlying its progression. Methods We integrated single-cell RNA sequencing, independent transcriptomic cohorts, clinical tissue analyses, functional assays, co-immunoprecipitation (Co-IP), multiple immunofluorescence labeling, and a xenograft model to investigate the cellular distribution, biological function, and mechanisms of regulation for matrix metalloproteinase 2 (MMP2) in GC. Results Single-cell analysis of paired tumor and adjacent normal tissues suggested an increased relative abundance of fibroblast populations and higher extracellular matrix-associated activity in GC tissues. MMP2 was preferentially expressed in cancer-associated fibroblasts, particularly in transcriptionally defined universal fibroblast-like and myofibroblastic CAF states. Trajectory analysis further suggested that the MMP2-high universal fibroblast-like population occupies an early and potentially transitional position along the fibroblast-state continuum. These findings were supported by an independent single-cell dataset, TCGA-STAD analysis, and tissue staining. In CAF–gastric cancer cell co-culture assays, CAFs enhanced tumor-cell migration and invasion, while modulation of the FBXW7–MMP2 axis altered these phenotypes. MMP2 overexpression promoted GC cell proliferation, migration, and invasion, whereas MMP2 silencing had the opposite effects. Mechanistically, FBXW7 interacted with the intracellular pool of MMP2, enhanced its K48-linked polyubiquitination, and reduced MMP2 protein stability through a proteasome-dependent process. FBXW7 overexpression attenuated MMP2-associated malignant phenotypes in vitro and restrained MMP2-driven tumor growth in vivo. Clinical tissue analyses further showed an inverse association between FBXW7 and MMP2 expression, while elevated MMP2 was associated with unfavorable survival. Conclusion Our findings identify MMP2-high fibroblast states as an important stromal feature of GC and reveal FBXW7-associated regulation of intracellular MMP2 stability as a potential therapeutic vulnerability.
It is demonstrated that MX1 promotes GC cell migration by suppressing ANXA2 ubiquitination and degradation, highlighting the critical role of the MX1-ANXA2 axis in GC progression.
Hang Yang, Huihan Ai, Zikun Wu et al.· Biochimica et Biophysica Act...· 0 citations
Clinically, these findings not only deepen the understanding of m6A-mediated posttranscriptional regulation in CRC but also identify this axis as a promising therapeutic target for overcoming ferroptosis resistance and improving patient outcomes.
Li-Chun Wang, Bin Guo, Xue-Ping Jiao et al.· Current Gene Therapy· 0 citations
The findings establish the TRIM2-DTNBP1 axis as a key driver of PCa progression and position TRIM2 as a promising prognostic biomarker and a potential predictive indicator for guiding molecularly targeted therapies in advanced PCa.
Jiang He, Sheng Liu, Wei Tong et al.· Frontiers in Molecular Biosc...· 0 citations
Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.
Xiu-Qi Li, Lin Shu, Xiao-Qiang Li et al.· Applied Biochemistry and Bio...· 0 citations
The results suggest that the pro-tumorigenic effects of XPR1 in thyroid carcinoma cells, manifested by increased cell growth, motility, invasiveness, and reduced susceptibility to apoptosis, may be partly associated with NF-κB signaling.
J. You, Tong-Xin Zou, Bo-Xiu Wang et al.· Discover medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.